<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25453">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775409</url>
  </required_header>
  <id_info>
    <org_study_id>16-000539</org_study_id>
    <nct_id>NCT02775409</nct_id>
  </id_info>
  <brief_title>Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction</brief_title>
  <official_title>Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is for women scheduled to have immediate breast reconstruction following
      mastectomy using a tissue expander. The primary purpose of this study is to learn whether
      there are differences in the outcome between placing the tissue expander above the muscle or
      below the muscle. The study will evaluate pain, wellbeing, and overall satisfaction with
      reconstruction. A secondary purpose is to learn whether there are differences in
      complications and costs between the two locations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patient satisfaction</measure>
    <time_frame>Baseline, Year 3</time_frame>
    <description>Difference in patient satisfaction between the two groups using the physical well being scale.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Breast Reconstruction Following Mastectomy</condition>
  <arm_group>
    <arm_group_label>Subcutaneous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subcutaneous placement of tissue expander</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Submuscular</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Submuscular placement of tissue expander</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subcutaneous placement</intervention_name>
    <description>The tissue expander will be placed above the muscle.</description>
    <arm_group_label>Subcutaneous</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Submuscular placement</intervention_name>
    <description>The tissue expander will be placed below the muscle</description>
    <arm_group_label>Submuscular</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women at least 18 years of age, who will undergo immediate unilateral or bilateral
             implant-based breast reconstruction following therapeutic skin-sparing or
             nipple-sparing mastectomy.

          2. Women at least 18 years of age, who will undergo immediate bilateral implant-based
             breast reconstruction following risk-reduction (prophylactic) skin-sparing or
             nipple-sparing mastectomy.

        Exclusion Criteria:

          1. Subjects who are unable to read or speak English.

          2. Patients desiring autologous reconstruction.

          3. BMI &gt;40.

          4. History of radiation therapy to the breast(s), e.g. history of breast conservation
             therapy.

          5. Current nicotine and/or tobacco use.

          6. Documented diagnosis of chronic pain.

          7. Women who are pregnant or breast-feeding *

          8. Women who decline the use of acellular dermal matrix (ADM).

          9. Surgeon decision not to proceed with tissue expander reconstruction.

         10. Women undergoing single stage (straight to implant) reconstruction.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minh-Doan Nguyen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sheri A Ramaker, RN</last_name>
    <phone>507-538-6984</phone>
    <email>ramaker.sheri@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheri A Ramaker, RN</last_name>
      <phone>507-538-6984</phone>
      <email>ramaker.sheri@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 29, 2017</lastchanged_date>
  <firstreceived_date>May 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Minh-Doan Nguyen</investigator_full_name>
    <investigator_title>Assistant Professor of Plastic Surgery</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Present/publish results at professional meetings/journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
